Idera Pharmaceuticals Inc (NASDAQ:IDRA)

1.89
Delayed Data
As of 4:00pm ET
 -0.02 / -1.05%
Today’s Change
1.32
Today|||52-Week Range
2.87
-10.43%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues73.0K249.0K16.2M902.0K
 
 
 
 
 
Depreciation And Amortization206.0K488.0K656.0K746.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses38.6M48.6M54.3M66.6M
 
 
 
 
 
Research And Development27.5M33.7M39.8M50.7M
 
 
 
 
 
Total Operating Expenses38.8M49.1M55.0M67.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-38.8M-48.8M-38.8M-66.5M
 
 
 
 
 
Interest Expense On Debt--105.0K80.0K50.0K
 
 
 
 
Other Expenses71.0K39.0K33.0K-41.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-38.6M-48.6M-38.4M-66.0M
 
 
 
 
 
Preferred Dividend-519.0K0.000.000.00
 
 
Net Income-38.6M-48.6M-38.4M-66.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS82.8M115.1M127.6M157.4M
 
 
 
 
 
Shares To Calculate EPS Diluted82.8M115.1M127.6M157.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.47-$0.42-$0.30-$0.42
 
 
 
 
 
EPS Diluted-$0.47-$0.42-$0.30-$0.42